Anterior cruciate ligament injury
Conditions
Interventions
Patients undergoing anterior cruciate ligament reconstruction under neuraxial anesthesia:None
Fascia iliaca space block group: 0.5% ropivacaine 30ml
Adductor canal block group: 0.5% ropivacaine 20ml
Femoral nerve block group: 0.5% ropivacaine 20ml
Sponsors
Beijing Jishuitan Hospital,Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Part I of the study:Patients undergoing anterior cruciate ligament reconstruction under neuraxial anesthesia Part ? of the study: (1) Patients receiving anterior cruciate ligament repair for the first time under neuraxial anesthesia and used hamstrings as a graft (2) Aged more than 18 years (3) The ASA I~IIII grade (4) Patients with informed consent (5) Surgery that starts before 2 p.m.
Exclusion criteria
Exclusion criteria: Part I of the study: (1) Aged more than 18 years (2) The patient combined with lower limb neuropathy (3) The patient combined with chronic pain or long-term use of analgesics (4) The patient refused to participate in this study Part ? of the study: (1) The patient combined with peripheral neuropathy (2) The patient combined chronic pain or long-term use of analgesics (3) There are contraindications to peripheral nerve block (local anesthetic allergy, coagulation dysfunction, infection at the operation site, etc.) (4) Other factors that prevent patients from cooperating with the study protocol (5) The surgery that was finished after 16:30
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical conditions;Postoperative analgesic protocol;The degree of pain;The nature of the pain;The location of the pain;Sufentanil dosage; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain-related effects;Adverse effects;Demographic data;Sufentanil dosage;NRS score for pain at rest;NRS score for motor pain;Incidence of nausea and vomiting and quadriceps muscle strength;Oral opioid dosage and patient satisfaction;Angle of motion of the knee and associated side effects; | — |
Countries
China
Contacts
Public ContactYan Wenjia
Beijing Jishuitan Hospital,Capital Medical University
Outcome results
None listed